While Bcl-3 overexpression was originally found to be associated with CLL and lymphomas, recent reports have shown that this oncogene is overexpressed in several solid tumors, such as breast [7], nasopharyngeal [8] and endometrial [9] carcinomas. The gene discussed is BCL3; the disease is carcinoma.